Debiopharm Group Investors
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug.
Industry:
Biotechnology
Estimated Revenue:
$4.7M.
Acquisitions Number:
Made Acquisitions
Number Of Exists:
5
Headquarters:
Lausanne, Vaud, Switzerland
Total Funding:
4700000
Last Funding Date:
2019-05-14 00:00:00
Last Funding Type:
Grant
Employee Number:
251-500
Investors Number:
20
Zip:
NA
Founded Date:
1979-01-01